THE FIRST EXPERIENCE OF TELBIVUDINE THERAPY IN LIVER TRANSPLANT PATIENTS
The first Russian experience of using telbivudine in liver transplant patients discussed in this article. Goal of telbivudine therapy in patients after liver transplantation was a prophylaxis and treatment of chronic hepatitis B recurrence. First data were received after 12 months since start of the...
Saved in:
Main Authors: | O. A. Gerasimova, D. A. Granov, F. K. Zherebtsov, V. V. Borovik |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2010-06-01
|
Series: | Вестник трансплантологии и искусственных органов |
Subjects: | |
Online Access: | https://journal.transpl.ru/vtio/article/view/287 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMPARATIVE RESULTS OF LIVER TRANSPLANTATION IN PATIENTS WITH VIRAL CIRRHOSIS AND AUTOIMMUNE LIVER DISEASES AT A SINGLE CENTER
by: O.A Gerasimova, et al.
Published: (2012-03-01) -
Non-infectivity of hepatitis B virus under nucleoside analog therapy revealed through auxiliary partial orthotopic liver transplantation
by: Xiaojie Chen, et al.
Published: (2025-07-01) -
Hepatitis B and reproductive health
by: M. V. Mayevskaya
Published: (2009-10-01) -
Extrahepatic malignant neoplasms after liver transplantation: the experience of a single transplant center
by: O. A. Gerasimova, et al.
Published: (2020-02-01) -
The use of sofosbuvir for the treatment of recurrent hepatitis C after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2017-03-01)